Cancer,THIS CURE FOR CANCER WAS DISCOVERED
42 YEARS AGO…BUT HAS BEEN SUPPRESSED SEVERAL TIMES.
IN 1976, DR. BURZYNSKI DISCOVERED A STRAIN OF PEPTIDES NEVER SEEN BEFORE.
HE ALSO DISCOVERED THAT PEOPLE WITH CANCER LACKED THESE PEPTIDES.
BURZYNSKI THEN STARTED GIVING PATIENTS A PEPTIDE CALLED ANTINEOPLASTON.
IN 1986, BURZYNSKI PRESENTED 40 CURED CANCER PATIENTS TO THE TEXAS MEDICAL BOARD.
2 YEARS LATER, THE BOARD TRIED TO REVOKE HIS MEDICAL LICENSE.
60 PATIENTS PETITIONED SAVI LIVE THE BOARD FOR FILING COMPLAINTS.A TRIAL ENSUED AND THE JUDGE FOUND BURZYNSKI NOT GUILTY OF ANY CRIME.
THE FDA THEN TOOK DR. BURZYNSKI TO FEDERAL COURT.
DOZENS OF CURED CANCER PATIENTS TESTIFIED FOR DR. BURZYNSKI.
I’ve had no chemotherapy. A chose Dr. Burzynski instead. after.a lot of research.
30+ CONGRESSMEN WROTE TO PERSUADE THE FDA TO ALLOW BURZYNSKI’S CLINICAL TRIALS.THE JUDGE DECLARED A MISTRIAL AND THE FDA LATER DROPPED ALL REMAINING CHARGES.
THE FDA THEN ALLOWED BURZYNSKITO PROCEED WITH PHASE I CLINICAL TRIALS.
HOWEVER, COURT CASES CONTINUED TÒ PLAGUE DR. BURZYNSKI FOR 20 MORE YEARS.
AFTER MANY SET BACKS THE FDA JUST RECENTLY APPROVED ONE OF HIS MEDICATIONS.
TWO OTHER MEDICATIONS ARE CURRENTLY IN FINAL APPROVAL.
TO SUPPORT HIS CLAIMS HE SHOWED Gaia RECENT PATIENT RESULTS.
THIS BRAIN TUMOR WENT INTO REMISSION IN 4 WEEKS.
THESE TUMORS IN THE LIVER DISAPPEARED IN 6 MONTHS.
HERE’S OVARIAN CANCER THAT HEALED IN 9 MONTHS.
According to W.H.O Report in 2022, Cancer is the leading cause of death worldwide, killing nearly 10 million people in 2020, or nearly one in six deaths.
The most common cancers are breast, lung, colon, rectalrectal, and prostate cancer. About a third of cancer deaths are linked to smoking, a high body mass index, alcohol consumption, low fruit and vegetable consumption, and lack of physical activity.
About 30% of cancers in low- and low-middle-income countries are caused by cancer-causing infections such as human papillomavirus (HPV) and hepatitis. Many types of cancer can be cured if detected early and treated effectively.
Each year, the American Cancer Society estimates the number of new.
Cancer is the leading cause of death worldwide, killing nearly 10 million people in 2020 (1). The most common cancers (in terms of new cancer cases) in 2020 were:
Breast (2.26 million cases);
Lungs (2.21 million cases);
Colon and rectum (1.93 million cases);
Prostate (1.41 million cases);
Skin (non-melanoma) (1.2 million cases); and
Stomach (1.09 million cases). The leading causes of cancer death in 2020 were:
lungs (1.8 million deaths);
colon and rectum (916,000 deaths);
Liver (830,000 deaths);
stomach (769,000 deaths); and
Breast cancer (685,000 deaths).
According to acsjournals,Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favorable in men compared to women. For example, lung cancer in women decreased at one half the pace of men (1.1% vs. 2.6% annually) from 2015 through 2019, and breast and uterine corpus cancers continued to increase, as did liver cancer and melanoma, both of which stabilized in men aged 50 years and older and declined in younger men. However, a 65% drop in cervical cancer incidence during 2012 through 2019 among women in their early 20s, the first cohort to receive the human papillomavirus vaccine, foreshadows steep reductions in the burden of human papillomavirus-associated cancers, the majority of which occur in women. Despite the pandemic, and in contrast with other leading causes of death, the cancer death rate continued to decline from 2019 to 2020 (by 1.5%), contributing to a 33% overall reduction since 1991 and an estimated 3.8 million deaths averted.
This progress increasingly reflects advances in treatment, which are particularly evident in the rapid declines in mortality (approximately 2% annually during 2016 through 2020) for leukemia, melanoma, and kidney cancer, despite stable/increasing incidence, and accelerated declines for lung cancer. In summary, although cancer mortality rates continue to decline, future progress may be attenuated by rising incidence for breast, prostate, and uterine corpus cancers, which also happen to have the largest racial disparities in mortality.